期刊文献+

肾透明细胞癌组织中Notch1的表达及意义 被引量:2

The expression and significance of Notch1 gene in the clear cel renal cel carcinoma
下载PDF
导出
摘要 目的:研究Notch1在肾透明细胞癌(clear cell renal cell carcinoma,ccRCC)组织中的表达变化情况,并探讨其相关临床意义。方法:采用免疫组化、实时荧光定量PCR技术检测52例肾透明细胞癌、40例癌旁肾组织中Notch1蛋白和mRNA的表达。结果:肾透明细胞癌及癌旁组织中Notch1蛋白阳性表达率分别为80.8%(42/52)、30.0%(12/40)(P<0.05);Notch1蛋白表达与肾透明细胞癌的TNM分期、Fuhrman分级、远处转移有关(P<0.05);肾透明细胞癌及癌旁组织中Notch1 mRNA相对表达量分别为0.317±0.044、0.153±0.038(P<0.05)。结论:Notch1蛋白及mRNA在肾透明细胞癌组织中表达明显增高。但在肾透明细胞癌发生、发展过程中的作用仍有待探讨。 Objective:To explore mRNA expression and significance of Notchl in clear cell renal cell carcinoma (ccRCC). Methods: Immunohistochemistry,real - time fluorescent quantitative PCR technique were selected to de-tect Notchl proteins and mRNA in 52 cases of ccRCC,40 cases of renal tissue adjacent to carcinoma. Results: Notchl protein positive expression rate in the ccRCC and the tissue adjacent to carcinoma were 80. 8% (42/52 ) , 30. 0%(12/40) ( P 〈 0. 05 ) . Notchl protein expression was correlated with TNM stage, grade of Fuhrman and distant metas-tasis (P〈0.05). Notchl mRNA relative expression in ccRCC and the tissue adjacent to carcinoma were 0.317 ± 0. 044,0. 153 ± 0. 038 ( P 〈 0. 05 ). Conclusion: Notchl is highly expressed in the ccRCC. Notchl may play a vital role in the development of the ccRCC,either promoting or inhibiting the carcinogenesis process.
出处 《现代肿瘤医学》 CAS 2018年第5期725-727,共3页 Journal of Modern Oncology
基金 山东省医药卫生科技发展计划面上项目(编号:2016WS0233)
关键词 肾细胞癌 NOTCH1 免疫组织化学 聚合酶链技术 renal cell carcinoma, Notchl, immunohistochemistry,PCR
  • 相关文献

参考文献3

二级参考文献57

  • 1马进元,于鹏,祝毓琳,朱步东.晚期或转移性非小细胞肺癌全身治疗进展[J].中国实用内科杂志,2013,33(S1):164-166. 被引量:18
  • 2Cairns J. Matters of life and death. Princeton: Princeton University Press, 1997.
  • 3Hanahan D, Weinberg RA. The hallmarks of cancer. Cell, 2000, 100( 1 ) :57-70.
  • 4Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell, 2011, 144 (5) : 646-674.
  • 5Lipponen P. Apoptosis in breast cancer: relationship with other pathological parameters. Endocr Relat Cancer, 1999,6 ( I ) : 13- 16.
  • 6Vakkala M, Pakk6 P, Soini Y. Expression of caspases 3, 6 and 8 is increased in parallel with apoptosis and histological aggressiveness of the breast lesion. Br J Cancer, 1999, 81 (4) : 592 -599.
  • 7Carrel A. Mechanism of formation and growth of malignant tumors. Ann Surg, 1925, 82(1) :1-13.
  • 8Yin C, Knudson CM, Korsmeyer SJ, et al. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature, 1997,385 (6617) : 637-640.
  • 9Knudson CM, Johnson GM, Lin Y, el al. Bax accelerates tumorigenesis in p53-deficient mice. Cancer Res, 2001, 61 (2) : 659 -665.
  • 10Luke JJ, Van De Wetering CI, Knudson CM. Lymphorna development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability. Cell Death Differ, 2003, 10(6) :740-748.

共引文献15

同被引文献9

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部